24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
Fax: (361)578-5500
Regular Hours: M-Fri 8am - 5pm
Every 3rd Thurs of the Month - Extended Hours Until 7 pm

Alzheimers Disease and other Cognitive Disorders
Basic Information
Introduction & Causes of Cognitive DisordersDementiaAlzheimer's DiseaseOther Cognitive DisordersDementia Coping Skills & Behavior ManagementTraumatic Brain Injury (TBI)Conclusion and Resources
More InformationLatest News
Long-Term Outlook for Most With Serious Brain Injury Is Better Than ThoughtDrug Shows Promise in Easing Dementia-Linked PsychosisAHA News: Diabetes and Dementia Risk: Another Good Reason to Keep Blood Sugar in Check1 in 20 Cases of Dementia Occurs in People Under 65Could Menopausal Hormone Therapy Reduce Women's Odds for Dementia?Reading, Puzzles May Delay Alzheimer's by 5 Years: StudyTwo Major Health Systems Won't Administer Controversial New Alzheimer's DrugMost Marriages Survive a Spouse's Brain InjuryMedicare Mulls Coverage for Controversial Alzheimer's DrugFDA Head Asks for Investigation Into Alzheimer's Drug ApprovalNew Prescribing Instructions Tighten Use of Controversial Alzheimer's DrugMissing Teeth, Higher Odds for Dementia?AHA News: Smoking Harms the Brain, Raises Dementia Risk – But Not If You QuitHealthy Living Can Lower Your Odds for Alzheimer'sKeeping Same Nurse for All Home Health Care May Be Crucial for Dementia PatientsMost Cases of Dementia in U.S. Seniors Go Undiagnosed: StudyLilly to Seek FDA Approval for New Alzheimer's DrugCould a Type of Statin Raise Dementia Risks?Good News, Bad News From Alzheimer's Vaccine TrialPoor Sleep After Head Injury Could Point to Dementia RiskFDA Approves Alzheimer's Drug Despite Expert Panel's ObjectionsFDA Defends Approval of Controversial Alzheimer's DrugPeople of Color Have Twice the Risk of Dying After Brain Injury, Study FindsIn People With Type 1 Diabetes, Poor Blood Sugar Control Could Raise Dementia RiskThere's Been a Shift in Who's Funding Alzheimer's ResearchHealthy Living Helps Prevent Dementia, Even If It Runs in the FamilyAHA News: Is It Normal Aging or Early Signs of Dementia?Failing Kidneys Could Bring Higher Dementia RiskDementia Risk Rises as Years Lived With Type 2 Diabetes IncreasesHead Injury, Alzheimer's Appear to Affect Brain in Similar WaysBrain Injuries Raise Long-Term Risk of StrokeResearch Shows Links Between Gum Disease and Alzheimer'sAssisted Living Centers Can Do More for Dementia Patients, Experts SayDiminished Hearing, Vision Together Could Be Risk Factor for Dementia6 Steps to Reduce Caregiver StressLoneliness in Mid-Life Linked to Higher Odds for Alzheimer'sDrug Used in Cancer Patients Might Help Treat Alzheimer's'Non-Drug' Approaches Can Fight Depression in People With DementiaSuicide Attempts Spike Soon After Dementia DiagnosisCould a New Drug Help Ease Alzheimer's?AHA News: Dementia May Be a Risk Factor for Infection But Not Death From COVID-19Your Eyes May Signal Your Risk for Stroke, DementiaEven 1 Concussion May Raise Your Odds for Dementia LaterAlzheimer's Patients Are Being Given Too Many MedsMany Blacks, Hispanics Believe They'll Get Worse Care If Dementia StrikesAlzheimer's May Strike Women and Men in Different WaysHistory of Mental Illness Tied to Earlier Onset of Alzheimer's DiseaseAHA News: Black, Hispanic Families Hit Hardest by DementiaWhy Some 'Super Ager' Folks Keep Their Minds Dementia-FreeDementia Seen in Younger Adults Shows Even More Brain Damage Than Alzheimer's
Questions and AnswersLinks
Related Topics

Anxiety Might Speed Alzheimer's: Study

HealthDay News
by By Amy Norton HealthDay Reporter
Updated: Nov 24th 2020

new article illustration

TUESDAY, Nov. 24, 2020 (HealthDay News) -- Older adults with memory problems may progress to Alzheimer's more quickly if they are also suffering from anxiety symptoms, a preliminary study suggests.

It's common for people with Alzheimer's disease to have mood symptoms, including anxiety and depression. And some research has suggested those symptoms can, in older people, act as early indicators of the dementia process.

The new study focused on 339 patients diagnosed with mild cognitive impairment -- persistent problems with memory and thinking skills that can progress to full-blown dementia.

But progression is not guaranteed, and people vary in how quickly their mental functioning declines.

There's no way to predict how things will go for any one person, said Dr. Maria Vittoria Spampinato, senior author on the study.

But researchers are trying to figure out whether certain factors are linked to the speed of progression. The new findings suggest anxiety might be one, according to Spampinato, a professor of radiology at the Medical University of South Carolina.

Her team found that patients with more anxiety symptoms at the outset were more likely to be diagnosed with Alzheimer's disease over the next several years, compared to those with few symptoms.

Does that mean anxiety speeds up the dementia process? Not necessarily, according to Mary Sano, director of the Alzheimer's Disease Research Center at Mount Sinai in New York City.

Instead, anxiety is likely another symptom of the underlying brain disease, said Sano, who was not involved in the study.

She doubted that treating anxiety in someone with mild cognitive impairment would "change the underlying biology" of the dementia process.

Still, Sano said, recognizing anxiety in those patients is still important. For one, it might serve as a red flag that someone is at risk of more rapid decline.

That's key, Sano said, partly because anxiety symptoms are easy to measure. In this study, some other factors were linked to faster progression -- including shrinkage in certain brain areas. But that can only be gauged with a brain MRI.

Plus, Sano said, helping people cope with anxiety should be a goal in its own right. "It's an important symptom to consider," she said.

The findings are based on a study of North American patients with mild cognitive impairment that involved memory problems. At the outset, all underwent anxiety and depression screening, MRI brain scans and blood tests.

Of 339 patients, 72 progressed to Alzheimer's over the next several years. Those with higher anxiety levels at the start tended to have a quicker progression -- as did patients with lower tissue volume in two brain areas involved in memory and learning.

Genes mattered, too: People carrying a gene variant linked to higher Alzheimer's risk -- ApoE4 -- also had a faster decline, compared to those with different variants.

Even with those other factors taken into account, though, anxiety was independently linked to a speedier progression, Spampinato said.

That alone, however, does not mean anxiety directly worsens cognitive problems.

"People living with mild cognitive impairment may experience anxiety, but what's unclear at this point is whether controlling or reducing anxiety may slow cognitive decline," said Heather Snyder, vice president of medical and scientific operations at the Alzheimer's Association.

She agreed with Sano on the importance of recognizing anxiety regardless.

"For individuals living with mild cognitive impairment or dementia," Snyder said, "managing anxiety and stress is an important aspect of providing care."

The Alzheimer's Association recommends some steps for patients and families: Simplify daily routines, make the home environment calm, and regularly fit in pleasant activities -- such as taking walks, gardening and listening to music.

Talking to a health care provider is always an option, too, Sano said.

"Sometimes older folks can be hesitant to talk about anxiety and depression," she noted. "But I think that's a mistake."

The study is scheduled to be presented Monday at the Radiological Society of North America's annual meeting, being held online. Findings reported at meetings are generally considered preliminary until they are published in a peer-reviewed journal.

More information

The Alzheimer's Association has more on anxiety and agitation.

SOURCES: Maria Vittoria Spampinato, MD, professor, radiology, Medical University of South Carolina, Charleston; Mary Sano, PhD, professor, psychiatry, and director, Alzheimer's Disease Research Center, Mount Sinai Icahn School of Medicine, New York City; Heather Snyder, PhD, vice president, medical and scientific operations, Alzheimer's Association, Chicago; Radiological Society of North America, online meeting presentation, Nov. 30, 2020